Vivo Capital Surplus Fund VIII, L.P., 10% Owner at Aligos Therapeutics, Inc. (ALGS), bought 1,073,726 shares at $15.00 ($8.3M) on 2020-10-20, disclosed to the SEC on 2020-10-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 523,726 | $0 | 0.0% |
| 2 | $15.00 | 66,733 | $1.0M | 12.1% |
| 3 | $15.00 | 483,267 | $7.2M | 87.9% |
| Total | $7.68 avg | 1,073,726 | $8.3M | 100% |
| Filing → |
| TERN | BUY | 2022-08-16 | $10.3M | — | Filing → |
| IMPL | BUY | 2021-04-29 | $8.6M | — | Filing → |
| CRNX | SELL | 2020-04-17 | $10.1M | — | Filing → |